Search results
Results from the WOW.Com Content Network
Teva Pharmaceutical has entered a business venture with Handok Pharmaceuticals of South Korea. In an effort to gain entrance into the Korean market, which Teva estimates to be $14 billion, it ...
In the South Korean context, a re-evaluation for listed drugs is a practical policy instrument that can make a major contribution to the rationalization of drug spending. In addition, the impact would be significant as it would affect the list and prices of new drugs, as the listed drugs could become the comparators for new drugs in the economic evaluation.
Pages in category "Pharmaceutical companies of South Korea" The following 7 pages are in this category, out of 7 total. This list may not reflect recent changes. A.
Chong Kun Dang (Korean: 종근당) is a South Korean multinational pharmaceutical company headquartered in Seoul. Founded as Goongbon Pharmacy under Japanese rule in 1941, it was renamed in 1946 and has since become one of the largest pharmaceutical manufacturers in the country.
SK pharmteco is a global contract development and manufacturing organization specializing in the production of active pharmaceutical ingredients (APIs), intermediates and viral vectors for cell and gene therapy for the pharmaceutical industry. SK Pharmteco operates six facilities in Europe, North America and Korea.
The Ministry of Food and Drug Safety (MFDS; Korean: 식품의약품안전처; Hanja: 食品醫藥品安全處; RR: Sikpumuiyakpumanjeoncheo), formerly known as the Korea Food & Drug Administration (KFDA; 식품의약품안전청), is a government agency responsible for promoting public health by ensuring the safety and effectiveness of foods, pharmaceuticals, medical devices, and cosmetics as ...
Celltrion, Inc. (Korean: 주식회사 셀트리온) is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. [2] Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. [3]
Hanmi Pharm Co., Ltd. (Korean: ... The company began moving into the European market in 1998. The company still was developing new drugs, with Paclitaxel in 2000, ...